文献速递主动脉疾病

使用开窗分支装置修复胸腹主动脉瘤和近肾腹主动脉瘤后八旬老人的结局支持治疗

Outcomes in octogenarians after thoracoabdominal and juxtarenal aortic aneurysm repair using fenestrated-branched devices justifies treatment.
PubMed 文献 · J Vasc Surg · 2022-10-28

单中心回顾性比较八旬老人与非八旬老人接受开窗分支腔内装置(F/BEVAR)修复胸腹主动脉瘤和近肾腹主动脉瘤的结局,并对比八旬老人生存与加拿大安大略省人群生存统计。八旬老人技术成功和术后不良结局无差异,4年后死亡率增加,4年生存与84岁安大略省人相当。

要点

  • 八旬老人与非八旬老人F/BEVAR术后院内死亡、卒中、脊髓缺血无显著差异。
  • 八旬老人6年生存显著低于非八旬老人(44.5% vs 64.1%;HR 1.96;P = .02)。
  • 八旬老人4年生存与84岁安大略省人相当(差异4.8%)。

核心结论

  • 八旬老人F/BEVAR技术成功和术后不良结局与年轻患者无差异,4年后死亡率增加,4年生存与84岁安大略省人相当,对适合干预的八旬老人安全有效。
  • 需要进一步研究术前患者选择和改善围手术期结局。

研究设计与样本

  • 单中心回顾性 review,2007年至2020年接受F/BEVAR的患者,中位随访3.3年(四分位距1.6-5.3)。
  • 纳入68例八旬老人(25.8%)和196例非八旬老人(74.2%),平均年龄83.5±3.0岁 vs 71.9±5.8岁(P ≤ .001)。
  • 从加拿大统计局公开数据获取平均84岁安大略省人(男女比4:1校正)的中位生存。

主要发现

  • 八旬老人最大动脉瘤尺寸显著更大(68.9±11.4 mm vs 65.4±10.0 mm;P = .017)。
  • 胸腹主动脉瘤修复数量(29.4% vs 38.3%;P = .19)和手术技术成功(92.6% vs 85.7%;P = .136)两组无差异。
  • 术后总体院内死亡(7.3% vs 5.1%;P = .49)、择期院内死亡(6.1% vs 4.4%;P = .49)、卒中(1.5% vs 3.6%;P = .384)、脊髓缺血(2.9% vs 9.2%;P = .094)两组无显著差异。
  • 4年生存两组无差异(62.9% vs 71.1%;P = .22),6年生存八旬老人显著更低(44.5% vs 64.1%;风险比1.96;P = .02)。
  • 6年再干预累积率(44.1% vs 41.3%;P = .84)和无分支不稳定率(67.6% vs 73.5%;P = .33)两组无差异。

临床怎么用

  • 对适合干预的八旬老人,F/BEVAR安全有效,技术成功和术后不良结局与年轻患者无差异。
  • 八旬老人4年后死亡率增加,4年生存与84岁安大略省人相当。
  • 作者认为需要进一步研究术前患者选择和改善围手术期结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare outcomes between octogenarians and nonoctogenarians undergoing thoracoabdominal aortic aneurysm repair and juxtarenal aortic aneurysm repair using branched and/or fenestrated endovascular devices (F/BEVAR) and compare octogenarian survival to population survival statistics from Ontario, Canada. METHODS: Patients who underwent F/BEVAR at a single institution between 2007 and 2020 were retrospectively reviewed with a median follow-up of 3.3 years (interquartile range, 1.6-5.3). The median survival of an average 84-year-old Ontarian from Canada, adjusted for a male:female ratio of 4:1, was retrieved from publicly available Statistics Canada data. RESULTS: In total, 68 octogenarians (25.8%) and 196 nonoctogenarians (74.2%) were included (mean age, 83.5 ± 3.0 vs 71.9 ± 5.8 years; P ≤ .001). The maximum aneurysm size was significantly larger in octogenarians (68.9 ± 11.4 mm vs 65.4 ± 10.0 mm; P = .017). No differences in the number of thoracoabdominal aortic aneurysm repairs (29.4% vs 38.3%; P = .19) or operative technical success (92.6% vs 85.7%; P = .136) were observed between the two cohorts. Postoperatively, no significant differences in overall in-hospital mortality (7.3% vs 5.1%; P = .49), elective in-hospital mortality (6.1% vs 4.4%; P = .49), stroke (1.5% vs 3.6%; P = .384), or spinal cord ischemia (2.9% vs 9.2%; P = .094) were seen between octogenarians and nonoctogenarians. There was no difference in survival at 4 years between the two cohorts (62.9% vs 71.1%; P = .22), however, survival at 6 years was significantly lower for octogenarians (44.5% vs 64.1%; hazard ratio, 1.96; P = .02). The cumulative rate of reintervention (44.1% vs 41.3%; P = .84) and freedom from branch instability (67.6% vs 73.5%; P = .33) at 6 years were not different between the two groups. When comparing octogenarians who survived to discharge from index hospitalization after F/BEVAR with 84-year-old Ontarians unmatched for comorbidities, a survival difference of 4.8% and 11.1% was noted at 4 and 6 years, respectively. CONCLUSIONS: F/BEVAR in octogenarians is associated with no differences in technical success or postoperative adverse outcomes when compared with their younger counterparts. Octogenarians had increased mortality after 4 years and their survival at 4 years was comparable with that of an 84-year-old Ontarian. F/BEVAR was safe and effective in octogenarians deemed fit for intervention. Further research into preoperative patient selection and improving perioperative outcomes is needed.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mahmood DN, Forbes SM, Rocha R, et al. Outcomes in octogenarians after thoracoabdominal and juxtarenal aortic aneurysm repair using fenestrated-branched devices justifies treatment. J Vasc Surg. 2022. PMID: 36441071. doi:10.1016/j.jvs.2022.10.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。